Global Toxin 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR012510318

Publication Date:

January 27, 2025

Pages:

105

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Toxin market size was valued at US$ 5350 million in 2024 and is forecast to a readjusted size of USD 10070 million by 2031 with a CAGR of 9.6% during review period.
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Global Toxin key players include Allergan, LIBP, Hugel, Ipsen, Medytox, etc. Global top five manufacturers hold a share about 90%.
Europe is the largest market, with a share over 10%, followed by APAC, and Middle East 锛� Africa, both have a share over 20%.
In terms of product, 50U is the largest segment, with a share about 55%. And in terms of application, the largest application is Cosmetic, followed by Medical, etc.
This report is a detailed and comprehensive analysis for global Toxin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Toxin market size and forecasts, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (US$/Vial), 2020-2031
Global Toxin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (US$/Vial), 2020-2031
Global Toxin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vial), and average selling prices (US$/Vial), 2020-2031
Global Toxin market shares of main players, shipments in revenue ($ Million), sales quantity (K Vial), and ASP (US$/Vial), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Toxin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Toxin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, US World Meds, Hugel, Daewoong, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Toxin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
50U
100U
Others
麻豆原创 segment by Application
Medical
Cosmetic
Major players covered
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Toxin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Toxin, with price, sales quantity, revenue, and global market share of Toxin from 2020 to 2025.
Chapter 3, the Toxin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Toxin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Toxin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Toxin.
Chapter 14 and 15, to describe Toxin sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Toxin Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 50U
1.3.3 100U
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Toxin Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical
1.4.3 Cosmetic
1.5 Global Toxin 麻豆原创 Size & Forecast
1.5.1 Global Toxin Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Toxin Sales Quantity (2020-2031)
1.5.3 Global Toxin Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Toxin Product and Services
2.1.4 Allergan Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Allergan Recent Developments/Updates
2.2 Ipsen
2.2.1 Ipsen Details
2.2.2 Ipsen Major Business
2.2.3 Ipsen Toxin Product and Services
2.2.4 Ipsen Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Ipsen Recent Developments/Updates
2.3 Medytox
2.3.1 Medytox Details
2.3.2 Medytox Major Business
2.3.3 Medytox Toxin Product and Services
2.3.4 Medytox Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Medytox Recent Developments/Updates
2.4 LIBP
2.4.1 LIBP Details
2.4.2 LIBP Major Business
2.4.3 LIBP Toxin Product and Services
2.4.4 LIBP Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 LIBP Recent Developments/Updates
2.5 Merz Pharmaceuticals
2.5.1 Merz Pharmaceuticals Details
2.5.2 Merz Pharmaceuticals Major Business
2.5.3 Merz Pharmaceuticals Toxin Product and Services
2.5.4 Merz Pharmaceuticals Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Merz Pharmaceuticals Recent Developments/Updates
2.6 US World Meds
2.6.1 US World Meds Details
2.6.2 US World Meds Major Business
2.6.3 US World Meds Toxin Product and Services
2.6.4 US World Meds Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 US World Meds Recent Developments/Updates
2.7 Hugel
2.7.1 Hugel Details
2.7.2 Hugel Major Business
2.7.3 Hugel Toxin Product and Services
2.7.4 Hugel Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Hugel Recent Developments/Updates
2.8 Daewoong
2.8.1 Daewoong Details
2.8.2 Daewoong Major Business
2.8.3 Daewoong Toxin Product and Services
2.8.4 Daewoong Toxin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Daewoong Recent Developments/Updates
3 Competitive Environment: Toxin by Manufacturer
3.1 Global Toxin Sales Quantity by Manufacturer (2020-2025)
3.2 Global Toxin Revenue by Manufacturer (2020-2025)
3.3 Global Toxin Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Toxin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Toxin Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Toxin Manufacturer 麻豆原创 Share in 2024
3.5 Toxin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Toxin 麻豆原创: Region Footprint
3.5.2 Toxin 麻豆原创: Company Product Type Footprint
3.5.3 Toxin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Toxin 麻豆原创 Size by Region
4.1.1 Global Toxin Sales Quantity by Region (2020-2031)
4.1.2 Global Toxin Consumption Value by Region (2020-2031)
4.1.3 Global Toxin Average Price by Region (2020-2031)
4.2 North America Toxin Consumption Value (2020-2031)
4.3 Europe Toxin Consumption Value (2020-2031)
4.4 Asia-Pacific Toxin Consumption Value (2020-2031)
4.5 South America Toxin Consumption Value (2020-2031)
4.6 Middle East & Africa Toxin Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Toxin Sales Quantity by Type (2020-2031)
5.2 Global Toxin Consumption Value by Type (2020-2031)
5.3 Global Toxin Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Toxin Sales Quantity by Application (2020-2031)
6.2 Global Toxin Consumption Value by Application (2020-2031)
6.3 Global Toxin Average Price by Application (2020-2031)
7 North America
7.1 North America Toxin Sales Quantity by Type (2020-2031)
7.2 North America Toxin Sales Quantity by Application (2020-2031)
7.3 North America Toxin 麻豆原创 Size by Country
7.3.1 North America Toxin Sales Quantity by Country (2020-2031)
7.3.2 North America Toxin Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Toxin Sales Quantity by Type (2020-2031)
8.2 Europe Toxin Sales Quantity by Application (2020-2031)
8.3 Europe Toxin 麻豆原创 Size by Country
8.3.1 Europe Toxin Sales Quantity by Country (2020-2031)
8.3.2 Europe Toxin Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Toxin Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Toxin Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Toxin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Toxin Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Toxin Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Toxin Sales Quantity by Type (2020-2031)
10.2 South America Toxin Sales Quantity by Application (2020-2031)
10.3 South America Toxin 麻豆原创 Size by Country
10.3.1 South America Toxin Sales Quantity by Country (2020-2031)
10.3.2 South America Toxin Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Toxin Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Toxin Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Toxin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Toxin Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Toxin Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Toxin 麻豆原创 Drivers
12.2 Toxin 麻豆原创 Restraints
12.3 Toxin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Toxin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Toxin
13.3 Toxin Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Toxin Typical Distributors
14.3 Toxin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.